Float Short %

2.28

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

6.26

Price

0.4

Target Price

10.39

Analyst Recom

1.33

Performance Q

170.66

Relative Volume

2.79

Beta

0.29

Ticker: CAMP

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-11-17	CAMP	3.97	N/A	N/A	0
2025-11-18	CAMP	3.96	N/A	N/A	0
2025-11-19	CAMP	3.76	N/A	N/A	0
2025-11-20	CAMP	3.53	N/A	N/A	0
2025-11-21	CAMP	2.92	N/A	N/A	0
2025-11-24	CAMP	3.4	N/A	N/A	0
2025-11-25	CAMP	3.38	N/A	N/A	0
2025-11-26	CAMP	3.64	N/A	N/A	0
2025-12-01	CAMP	3.23	N/A	N/A	0
2025-12-02	CAMP	3.31	N/A	N/A	0
2025-12-03	CAMP	3.24	N/A	N/A	0
2025-12-04	CAMP	3.38	N/A	N/A	0
2025-12-05	CAMP	3.33	N/A	N/A	0
2025-12-08	CAMP	3.58	N/A	N/A	0
2025-12-09	CAMP	4.59	N/A	N/A	0
2025-12-10	CAMP	5.71	N/A	N/A	0
2025-12-11	CAMP	6.12	N/A	N/A	0
2025-12-12	CAMP	6.42	N/A	N/A	0
2025-12-15	CAMP	6.62	N/A	N/A	0
2025-12-16	CAMP	7	N/A	N/A	0
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-11-17	CAMP	0	7.98	2.14
2025-11-18	CAMP	24.62	7.98	2.14
2025-11-19	CAMP	24.62	7.98	2.14
2025-11-20	CAMP	24.62	7.98	2.14
2025-11-21	CAMP	24.62	7.98	2.18
2025-11-24	CAMP	24.24	19.46	2.18
2025-11-25	CAMP	24.24	19.46	2.18
2025-11-26	CAMP	24.24	19.46	2.34
2025-12-01	CAMP	24.24	19.46	2.34
2025-12-02	CAMP	24.24	19.46	2.34
2025-12-03	CAMP	24.24	19.46	2.34
2025-12-04	CAMP	24.24	19.46	2.34
2025-12-05	CAMP	24.24	19.46	2.34
2025-12-08	CAMP	24.24	19.46	2.34
2025-12-09	CAMP	24.24	19.46	2.34
2025-12-10	CAMP	24.24	19.46	2.28
2025-12-11	CAMP	24.24	19.46	2.28
2025-12-12	CAMP	24.24	19.46	2.28
2025-12-15	CAMP	24.24	19.46	2.28
2025-12-16	CAMP	24.24	19.46	2.28
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

-2.04

Avg. EPS Est. Next Quarter

-1.15

Insider Transactions

24.24

Institutional Transactions

19.46

Beta

0.29

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

99.9

Max Drawdown 5-Year %

-99.9

Target Price

10.39

P/E

Forward P/E

PEG

P/S

86.48

P/B

5.6

P/Free Cash Flow

EPS

-2.45

Average EPS Est. Cur. Y

-5.27

EPS Next Y. (Est.)

0.99

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-1404.47

Relative Volume

2.79

Return on Equity vs Sector %

84.2

Return on Equity vs Industry %

113.5

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

CAMP4 THERAPEUTICS CORPORATION

Sector: Healthcare

Industry: Biotechnology

Employees: 55

Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops regulatory RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate is CMP-CPS-001, which is in a Phase 1 clinical trial for the treatment of urea cycle disorders. The company also develops CMP-SYNGAP for the treatment of SYNGAP1-related disorders. Camp4 Therapeutics Corporation was formerly known as Marauder Therapeutics, Inc. and changed its name to Camp4 Therapeutics Corporation in March 2018. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

stock quote shares CAMP – CalAmp Corp. Stock Price stock today

news today CAMP – CalAmp Corp. stock forecast ,stock prediction 2023 2024 2025

marketwatch CAMP – CalAmp Corp. yahoo finance google finance

stock history CAMP – CalAmp Corp. invest stock market

stock prices CAMP premarket after hours

ticker CAMP fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: CAMP

No data found

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y